Your browser doesn't support javascript.
loading
Canagliflozin, a sodium-glucose cotransporter 2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats.
Kimura, Yukishige; Kuno, Atsushi; Tanno, Masaya; Sato, Tatsuya; Ohno, Kouhei; Shibata, Satoru; Nakata, Kei; Sugawara, Hirohito; Abe, Koki; Igaki, Yusuke; Yano, Toshiyuki; Miki, Takayuki; Miura, Tetsuji.
Afiliación
  • Kimura Y; Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kuno A; Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Tanno M; Department of Pharmacology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Sato T; Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Ohno K; Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Shibata S; Department of Cellular Physiology and Signal Transduction, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Nakata K; Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Sugawara H; Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Abe K; Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Igaki Y; Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Yano T; Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Miki T; Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Miura T; Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
J Diabetes Investig ; 10(4): 933-946, 2019 Jul.
Article en En | MEDLINE | ID: mdl-30663266
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estrés Oxidativo / Diabetes Mellitus Tipo 2 / Lesión Renal Aguda / Síndrome Cardiorrenal / Canagliflozina / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Infarto del Miocardio Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Animals Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estrés Oxidativo / Diabetes Mellitus Tipo 2 / Lesión Renal Aguda / Síndrome Cardiorrenal / Canagliflozina / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Infarto del Miocardio Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Animals Idioma: En Año: 2019 Tipo del documento: Article